NEW YORK (GenomeWeb News) – Celera Corporation and Abbott announced today that they have revised their strategic alliance agreement, moving from a profit-sharing deal to new worldwide distribution and royalty agreements.

Under one of these agreements, Abbott will have the right to exclusively distribute certain Celera-manufactured molecular diagnostic products. A second agreement gives Celera royalties on sales of m2000 real-time PCR system reagents, instruments, services, and related consumables.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.